Discover Breakthrough COPD & Regenerative Medicine Insights at RIS 2025
Are you attending the Respiratory Innovation Summit (RIS) in San Francisco (May 16-18)? If so, we invite you to explore the cutting edge of regenerative medicine with SMSbiotech.
Our President and Chief Scientific Officer, Dr. Abdulkader Rahmo, will be presenting a compelling scientific poster titled: "Regenerative Medicine: Small Mobile Stem Cells Unlock Multi-Targeted Tissue Regeneration for COPD and Beyond."
This groundbreaking research unveils the remarkable potential of our proprietary Small Mobile Stem (SMS) Cells to revolutionize the treatment of chronic obstructive pulmonary disease (COPD) and other debilitating age-related and degenerative conditions. Dr. Rahmo's presentation will delve into the science behind how SMS Cells can offer a multi-targeted approach to tissue regeneration, representing a significant leap forward in therapeutic possibilities.
Why This Matters to You:
- Uncover Novel Therapeutic Strategies: Learn about a unique stem cell-based approach that could transform the landscape of COPD and other chronic disease treatments.
- Gain Insights into Multi-Targeted Regeneration: Understand the innovative mechanisms by which SMS Cells promote tissue repair and regeneration across multiple pathways.
- Explore Potential Collaborations: For fellow researchers, clinicians, and biotech innovators, this is an opportunity to discuss potential partnerships and the future of regenerative medicine.
- Meet the Visionary Behind the Science: Dr. Rahmo is a leading expert in the field, and this is your chance to engage directly with him and learn firsthand about SMSbiotech's pioneering work.
Our team attending RIS represents a wealth of expertise across the spectrum of our research and clinical development. We encourage you to connect with the following individuals to explore potential synergies:
- For discussions on the foundational science and strategic vision: Engage with Dr. Abdulkader Rahmo, President and Chief Scientific Officer.
- To delve into our clinical trial strategies and research design: Connect with Dr. Roger Schechter, Clinical Research Director.
- For insights into our global clinical program specifically for respiratory indications: Reach out to Jason P. Kirkness, PhD (Medicine) ATSF, Global Clinical Program Lead for Respiratory.
- To explore broader partnership opportunities, investing, and company updates: Please connect with Bret Williams.
The Respiratory Innovation Summit is the ideal platform to connect with the forefront of respiratory science and therapeutic development. Dr. Rahmo's presentation underscores SMSbiotech's unwavering commitment to developing innovative solutions for complex pulmonary conditions and the aging population.
Don't Miss This Opportunity:
We encourage you to visit Dr. Rahmo's poster session to learn more.
Interested in scheduling a dedicated meeting with Dr. Rahmo during the RIS Conference?
Please reach out to Dr. Rahmo at a.rahmo@smsbiotech.com to set up a meeting.
We look forward to connecting with you at RIS 2025 and sharing our exciting advancements in regenerative medicine.
